Prosecution Insights
Last updated: October 02, 2026
Application No. 19/077,772

CELL DETACHMENT METHOD AND CELL DETACHMENT SYSTEM

Non-Final OA §103
Filed
Mar 12, 2025
Priority
Mar 15, 2024 — JP 2024-040945
Examiner
THUESON, HANNA MARIE
Art Unit
Tech Center
Assignee
Canon Inc.
OA Round
1 (Non-Final)
77%
Grant Probability
Favorable
1-2
OA Rounds
1y 11m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 77% — above average
77%
Career Allowance Rate
23 granted / 30 resolved
+16.7% vs TC avg
Strong +28% interview lift
Without
With
+28.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
25 currently pending
Career history
59
Total Applications
across all art units

Statute-Specific Performance

§101
2.2%
-37.8% vs TC avg
§103
63.5%
+23.5% vs TC avg
§102
19.3%
-20.7% vs TC avg
§112
13.3%
-26.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 30 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 1-8 are rejected under 35 U.S.C. 103 as being unpatentable over Nishishita et al. (WO/2023/140302) in view of Watakabe et al. (US 2015/0315537 A1) Regarding claims 1 and 7: Nishishita teaches an automated method of using a discharge solution to detach cells in culture. (Abstract) This method may include use of automated shaking. (0014) Specifically, Nishishita teaches that a drawback of using only shaking to dislodge cells, even automated, requires a length of time of continuous shaking which damages the cells in culture. (0009) To remedy this drawback, Nishishita specifies a method of shaking the culture container during the cell dissociation step to encourage detachment. (0014) Furthermore, Nishishita defines “physical exfoliation” of the culture vessel to mean applying shaking, vibration, or ultrasonic treatment to the culture vessel. (0022) Nishishita fails to explicitly disclose use of tapping of the culture vessel or tapping/shaking in multiple directions. Watakabe teaches a cell detachment device including a base, vessel holder, guide mechanism, collided member, urging member, and power imparting mechanism. (57) Specifically, Watakabe seeks to automate the cell detachment process and fully automate tapping (0007) of the cell culture vessel. Watakabe further teaches that the configuration of the device allows for the vessel holder (containing the cell culture vessel) to be moved in a direction both away from the collided member (0014) and towards the collided member (0015). This reads on a cell detachment method using a cell detachment system comprising tapping said culture vessel in first and second directions different from each other as viewed in a direction perpendicular to the culture surface. Watakabe further discloses that the configuration of the device further allows for the vessel to continue vibrating after colliding with the collided member. (0022) Regarding claims 2 and 3: Nishishita teaches that the discharge angle may be anywhere between 0-90 degrees and defines the discharge angle to mean the angle at which the cells are discharged relative to the surface of the culture vessel adhered to them. (0070) This reads on both claim 2 of use of an angle of more than 30 degrees to less than 150 degrees and claim 3 of use of an angle of more than 45 degrees and less than 135 degrees. Regarding claim 4 and 5: Nishishita fails to explicitly teach the tapping of the culture vessel, however Watakabe states use of automated tapping within the configuration of the device, allowing for a vibration and impact shock to be applied regularly to the culture vessel. (0013) As discussed above, Nishishita teaches use of shaking of the culture vessel and Watakabe teaches tapping of the culture vessel. Neither Nishishita nor Watakabe teach specific rates of tapping or shaking, as this is something typically optimized by a person skilled in the art and may vary greatly based on cell type, culture conditions, and stage of growth. Furthermore, as discussed above, Nishishita teaches that rapid and sustained shaking of the culture vessel will damage the cells. (0009) As such, it would be obvious to a person of ordinary skill in the art to have a rate of tapping which is greater than the rate of shaking so as to avoid damage to the cells in culture. Regarding claim 6: Nishishita teaches use of physical exfoliation to stimulate the entire culture vessel during the process of cell detachment and details use of an ultrasonic treatment as a method of exfoliation. (0022) It would have been obvious to one skilled in the art to combine the teachings of tapping of the culture vessel in an automated fashion by Watakabe with the protocol for mechanical cell detachment taught by Nishishita. One skilled in the art would have motive to combine and a reasonable expectation of success based on the teachings of Watakabe, who states that the automation of tapping allows for agitation in the form of tapping to apply impact shock throughout the dissociation process. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to HANNA M THUESON whose telephone number is (571) 272-3680. The examiner can normally be reached M-F 7:30-5 EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner's supervisor, Tracy Vivlemore, can be reached on (571) 272-2914. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /HANNA MARIE THUESON/Examiner, Art Unit 1638 /Tracy Vivlemore/Supervisory Primary Examiner, Art Unit 1638
Read full office action

Prosecution Timeline

Mar 12, 2025
Application Filed
Sep 08, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12735723
Self-Complementary Adeno-Associated Virus Vector and its Use in Treatment of Muscular Dystrophy
3y 9m to grant Granted Sep 15, 2026
Patent 12702720
GENOMIC INSULATOR ELEMENT EXHIBITING ENHANCER BLOCKING ACTIVITIES IN LYMPHOCYTES AND USES THEREOF
3y 9m to grant Granted Aug 11, 2026
Patent 12692515
ARTIFICIAL EXPRESSION CONSTRUCTS FOR SELECTIVELY MODULATING GENE EXPRESSION IN INHIBITORY NEOCORTICAL NEURONS
3y 7m to grant Granted Jul 28, 2026
Patent 12673982
Engineered Artificial Antigen Presenting Cells for Tumor Infiltrating Lymphocyte Expansion
5y 2m to grant Granted Jul 07, 2026
Patent 12674140
MYOGENIN-EXPRESSING FIBROBLAST-LIKE CELL (MEFLC) LINE AND CONSTRUCTION METHOD AND USE THEREOF
3y 3m to grant Granted Jul 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
77%
Grant Probability
99%
With Interview (+28.2%)
3y 6m (~1y 11m remaining)
Median Time to Grant
Low
PTA Risk
Based on 30 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month